PD-L1,TRAPPC4

Maria Anele Romeo1, Maria Saveria Gilardini Montani1, Roberta Santarelli1

  • 1Department of Experimental Medicine, "Sapienza" University of Rome, Viale Regina Elena 324, 00161, Rome, Italy.

Discover oncology
|August 21, 2023
PubMed
概括

酸 (VPA) 是一种HDAC抑制剂,通过增强基因转录和蛋白质乙化来增加胰腺癌细胞的PD-L1. 将VPA与像JQ-1这样的BRD4抑制剂结合起来,可能会改善癌症治疗结果.